about
Zika Virus as a Cause of Neurologic DisordersSystematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopyUntreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysisHarmonisation of Zika virus research protocols to address key public health concerns.Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendationsCosting of National STI Program Implementation for the Global STI Control Strategy for the Health Sector, 2016-2021.Prevalence and risk factors associated with sexually transmitted infections (STIs) among women of reproductive age in Swaziland.Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data.The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a modelRisk of bias and confounding of observational studies of Zika virus infection: A scoping review of research protocolsPhenotypic variation of Helicobacter pylori isolates from geographically distinct regions detected by lectin typingA road map for the global elimination of congenital syphilisEffectiveness of interventions to improve screening for syphilis in pregnancy: a systematic review and meta-analysis.A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Preliminary Report.Early antenatal care: does it make a difference to outcomes of pregnancy associated with syphilis? A systematic review and meta-analysis.The cost-effectiveness of 10 antenatal syphilis screening and treatment approaches in Peru, Tanzania, and Zambia.Maternal and congenital syphilis programmes: case studies in Bolivia, Kenya and South Africa.Estimating Benzathine Penicillin Need for the Treatment of Pregnant Women Diagnosed with Syphilis during Antenatal Care in High-Morbidity Countries.The Performance of the Vaginal Discharge Syndromic Management in Treating Vaginal and Cervical Infection: A Systematic Review and Meta-AnalysisPrevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, SwazilandGlobal control of sexually transmitted infections.The elimination of congenital syphilis: a comparison of the proposed World Health Organization action plan for the elimination of congenital syphilis with existing national maternal and congenital syphilis policies.The need and plan for global elimination of congenital syphilis.Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania.Congenital syphilis re-emerging.Ensuring access to HPV vaccines through integrated services: a reproductive health perspectiveHIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy.Effective health interventions for adolescents that could be integrated with human papillomavirus vaccination programs.Reaching beyond pregnant women to eliminate mother-to-child transmission of syphilis in Africa.Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia.Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling.Sexually transmitted infections and women's sexual and reproductive health.Global burden of maternal and congenital syphilis in 2008 and 2012: a health systems modelling study.Implementation of a study to examine the persistence of Ebola virus in the body fluids of Ebola virus disease survivors in Sierra Leone: Methodology and lessons learned.Development of risk reduction behavioral counseling for Ebola virus disease survivors enrolled in the Sierra Leone Ebola Virus Persistence Study, 2015-2016.Health systems and the new strategy against sexually transmitted infections.World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer.Can the Perinatal Information System in Peru be used to measure the proportion of adverse birth outcomes attributable to maternal syphilis infection?Vaccines against sexually transmitted infections: the way forward.
P50
Q24261288-38D3AF5B-DDDA-4A79-8C36-E364A71EC5EEQ26768543-F7F49DA1-683D-4A13-96CE-5060A630032BQ26849766-94D7A5EF-1791-44C0-954B-03EE987E7429Q27674421-06606F80-8717-49B7-9F8D-79C78A450F28Q28076370-416B5CB9-01E1-42B4-B526-5D9E4CCB758BQ29247953-DACC9495-5E65-4E4E-885A-6760706BDD7FQ30376834-6E0B2944-671A-4818-845C-12E098EC13DAQ30596983-D17D1AFA-24B5-4E60-BDC2-73B4BC6EFFA9Q31149510-17773E90-F1A1-4D15-9951-680EA8CA0D40Q33883729-06DCFB63-D728-466B-8E78-33A187BA76CAQ33946030-B7284018-19B3-4A85-9DCF-A5C079B17760Q34035379-1C3A8C28-7344-4A1F-8BBD-44CA2ABE13B7Q34193555-2F6665AC-65DE-45A0-9525-3BDD81EE6F4AQ34475118-B02FE2CF-8EA3-4DDE-AE70-7740E267E447Q34497945-C0DB7519-6DB4-4F45-8B2F-302B4FAD1A82Q34611538-12F6A78B-89AA-481B-95D5-6B69E767D540Q35876702-C0DF7CF4-5AFF-4C12-8661-8DBCDA629034Q35882370-EE7BD3FF-94E2-4941-92C8-8D8B601ABC42Q36081756-116CCC01-3680-4971-BC24-9BCD642E5EB1Q36153638-3DF9032F-D573-4B2D-9502-335FCCE7DB4BQ36257446-C63B3179-6B10-494D-9D43-177CDEBA60D7Q36671683-8A1E2285-605F-4571-B223-C215C6210CFDQ36860525-7D0786F3-EBC2-4BEB-911F-6F393CA4A7FAQ36860531-61E3151F-0599-4F29-A253-2101EEBBE562Q37027145-6A90D00C-D01E-4C1F-BF09-A47C02247A79Q37081719-A878D4C0-4263-4932-B119-300161086803Q37084482-8CF96466-E6F8-4422-8E9E-4084C7DE3174Q37305354-06AD8DD8-DF96-460F-8BE3-7627305215F4Q38104123-AFED0D9F-458A-481B-8413-A8B5C7B0A72FQ38212256-FC846D0E-8AE9-4BDA-9576-415C8DC0A7A7Q38661394-A1678201-60E0-4DCF-8A67-7A208175665DQ38667180-C9202BD3-709A-47F9-90AF-580C895CC081Q39329108-F6623AD8-FC6D-46CA-A7F4-AA8F6B7320AEQ39574824-A297E9D2-7A04-4656-A5C5-A2FCCBAD9B40Q40037619-727A5489-B9E9-420F-A34F-ACD58ED551E6Q40039650-F0129352-7166-45B1-9233-B2BB43B9127FQ40137670-C6AF6CF5-0027-45F6-BD26-4138DA5B3BA3Q40915197-DCA7C07A-1E73-4072-901F-4214A048CC62Q41688691-630467A1-121A-4AAF-8AAC-742400B5FE80Q42230455-CB6081C6-9CB9-4008-A5EF-92F42B602B13
P50
name
Nathalie Broutet
@ast
Nathalie Broutet
@en
Nathalie Broutet
@nl
type
label
Nathalie Broutet
@ast
Nathalie Broutet
@en
Nathalie Broutet
@nl
prefLabel
Nathalie Broutet
@ast
Nathalie Broutet
@en
Nathalie Broutet
@nl